Average Co-Inventor Count = 8.19
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
2. Schering Corporation (5 from 1,829 patents)
3. Schering Coporation (1 from 3 patents)
16 patents:
1. 11752128 - Benzimidazoles and indoles as taro inhibitors
2. 11738010 - Oxazolidinones as TarO inhibitors
3. 11413292 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
4. 11141403 - Benzimidazoles and indoles as taro inhibitors
5. 11141410 - Oxazolidinones as taro inhibitors
6. 9206142 - Anilinopiperazine derivatives and methods of use thereof
7. 8603998 - Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
8. 8586576 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
9. 8580782 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
10. 8476278 - Thiazole Derivatives as protein kinase inhibitors
11. 8114879 - Piperazine derivatives useful as CCR5 antagonists
12. 7605155 - Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
13. 7384944 - Piperazine derivatives useful as CCR5 antagonists
14. 7196078 - Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
15. 6689765 - Piperazine derivatives useful as CCR5 antagonists